Titre:
  • A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3
Auteur:Foster, Graham Russell; Heo, Jeong; Kumada, Hiromitsu; Lu, Sheng Nan; Marcellin, Patrick; Moreno, Christophe; Roberts, Stuart Keith Eith S.K.; Strasser, Simone; Thompson, Alexander James V A.J.; Toyota, Joji; Paik, Seung Woon; Chayama, Kazuaki; Vierling, John J.M.; Zignego, Anna Linda; Cohen, David; McPhee, Fiona; Wind-Rotolo, Megan; Srinivasan, Subasree; Hruska, Matthew; Myler, Heather; Portsmouth, Simon S.D.; Chuang, Wan Long; Fainboim, Hugo; Färkkilä, Martti; Gadano, Adrian; Gaeta, Giovanni Battista Attista G.B.; Hezode, Christophe; Inada, Yukiko
Informations sur la publication:SpringerPlus, 5, 1, 1365
Statut de publication:Publié, 2016-12
Sujet CREF:Technologie de la sécurité
Mots-clés:Genotype 2
Genotype 3
Hepatitis C virus
Peginterferon alfa-2a
Peginterferon lambda-1a
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:2193-1801
info:doi/10.1186/s40064-016-2920-z
info:scp/84983285013